Loading...
A new bromelain-based enzyme for the release of Dupuytren’s contracture: Dupuytren’s enzymatic bromelain-based release
OBJECTIVES: Injectable Bromelain Solution (IBS) is a modified investigational derivate of the medical grade bromelain-debriding pharmaceutical agent (NexoBrid) studied and approved for a rapid (four-hour single application), eschar-specific, deep burn debridement. We conducted an ex vivo study to de...
Na minha lista:
| Udgivet i: | Bone Joint Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4921045/ https://ncbi.nlm.nih.gov/pubmed/27174554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1302/2046-3758.55.BJR-2016-0072 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|